Try our corporate solution for free!
(212) 419-8286

Pharmaceutical revenue of Merck & Co. by therapy class 2019

Merck and Co. generates the majority of its worldwide revenue from its pharmaceutical operating segment. Sales from the company’s oncology franchise, which focuses on drugs that treat cancer, accounted for the largest single share of its pharmaceutical revenue in 2019.

Revenues boosted by sales of cancer treatments

Merck & Co. is a global healthcare company that generated approximately 46.8 billion U.S. dollars in total revenue in 2019. The company has two reportable operating segments: pharmaceutical and animal health. The pharmaceutical segment is split into ten franchises - or therapeutic areas; the oncology franchise generated over 12 billion U.S. dollars in 2019 – a significant increase compared to the previous year. Sales of cancer drug Keytruda were particularly strong and increased from 7.17 billion in 2018 to over 11 billion U.S. dollars in 2019.

An overview of Merck’s global operations

The corporate headquarters of Merck & Co. is located in New Jersey, and the company’s domestic market is the region that continues to generate the most of its revenue. Outside of the United States, Merck & Co. has operations in Europe, the Middle East, Africa, Asia Pacific, and Latin America. The company’s sales in the Asia Pacific (excluding China and Japan) region stayed almost the same between 2017 and 2019. Operating business strategies in emerging markets, such as China, can come with challenges, but they offer huge potential for growth over time.

Pharmaceutical revenue of Merck & Co. in 2019, by therapy area

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

February 2020



Survey time period


Supplementary notes

* These amounts do not reflect sales of vaccines sold in most major European markets through the Company’s joint venture, Sanofi Pasteur MSD, the results of which are reflected in Equity income from affiliates. These amounts do, however, reflect supply sales to Sanofi Pasteur MSD.
** Other pharmaceutical primarily reflects sales of other human health pharmaceutical products, including products within the franchises not listed separately.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Merck & Co."

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.